We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$6.98M
Cap. Flow
-$27.2M
Cap. Flow %
-8.32%
Top 10 Hldgs %
35.72%
Holding
92
New
32
Increased
20
Reduced
19
Closed
20

Top Buys

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$9.19M
2
SNY icon
Sanofi
SNY
+$6.44M
3
ABT icon
Abbott
ABT
+$6.09M
4
CNC icon
Centene
CNC
+$5.9M
5
EHTH icon
eHealth
EHTH
+$5.67M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$13.7M
2
LHCG
LHC Group LLC
LHCG
+$9.87M
3
BMY icon
Bristol-Myers Squibb
BMY
+$9.03M
4
DHR icon
Danaher
DHR
+$7.96M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$7.65M

Sector Composition

Rank Sector Weight
1 Healthcare 85.4%
2 Energy 4.88%
3 Financials 1.69%
4 Consumer Discretionary 0.59%
5 Technology 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRN
76
Amarin Corp
AMRN
$299M
– –
-17,500
Closed -$2.42M
AZN icon
77
AstraZeneca
AZN
$244B
– –
-62,500
Closed -$6.61M
DGX icon
78
Quest Diagnostics
DGX
$26.3B
– –
-120,000
Closed -$13.7M
DHR icon
79
Danaher
DHR
$145B
– –
-50,760
Closed -$7.96M
EXAS
80
DELISTED
Exact Sciences
EXAS
– –
-55,000
Closed -$4.78M
EXEL icon
81
Exelixis
EXEL
$12.7B
– –
-150,000
Closed -$3.56M
INCY icon
82
Incyte
INCY
$24.6B
– –
-10,000
Closed -$1.04M
LLY icon
83
Eli Lilly
LLY
$1.09T
– –
-35,000
Closed -$5.75M
NBIX icon
84
Neurocrine Biosciences
NBIX
$16B
– –
-20,000
Closed -$2.44M
REGN icon
85
Regeneron Pharmaceuticals
REGN
$82B
– –
-12,000
Closed -$7.48M
WBA
86
DELISTED
Walgreens Boots Alliance
WBA
– –
-40,000
Closed -$1.7M
ITCI
87
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-100,000
Closed -$2.57M
SGEN
88
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-45,000
Closed -$7.65M
NUVA
89
DELISTED
NuVasive, Inc.
NUVA
– –
-125,000
Closed -$6.96M
BMY.RT
90
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-150,000
Closed -$537K
MNTA
91
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-150,000
Closed -$4.99M
ZGNX
92
DELISTED
Zogenix, Inc.
ZGNX
– –
-90,000
Closed -$2.43M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Integral Health Asset Management held 92 positions worth $327M, down 2.1% from $334M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management withdrew a net $27.2M in Q3 2020, closing 20 positions and reducing 19 holdings. Its most notable exit was Quest Diagnostics, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Energy and Financials.

Against the trend, Integral Health Asset Management opened a new position in Sanofi worth $6.27M.

  • Integral Health Asset Management's largest Q3 2020 buy was Sanofi: 125,000 shares worth $6.27M.
  • Integral Health Asset Management added most to Revvity in Q3 2020, an estimated $9.19M increase.
  • Integral Health Asset Management's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $9.87M.
  • Integral Health Asset Management fully exited Quest Diagnostics in Q3 2020, selling an estimated $13.7M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $327M portfolio in Q3 2020.
  • Integral Health Asset Management opened 32 new positions and closed 20 in Q3 2020.
  • Integral Health Asset Management's portfolio value fell 2.1% quarter-over-quarter to $327M.

Based on Integral Health Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.